***Please note that, in order to access these course materials, you must create a user profile if you do not already have one. Your profile one ScientiaCME's website is unrelated to your profile on North American Thrombosis Forum's (NATF's) website.***
The content of this online activity was presented originally at a live event. It is divided into three videos. Learners must view both videos in their entirety and complete a post-activity assessment and evaluation before they are eligible for continuing credit.
The North American Thrombosis Forum's (NATF’s) “5th Right Heart Symposium”
The syndrome of right heart failure is poorly understood and defined. Clinicians often fail to diagnose early stages of the disease and allow the manifestations to progress to severe disability. There is a pressing need to define, understand, and inculcate awareness about this disease in clinicians. Similarly, understanding right heart dysfunction requires focused investigations and research study, best brought forth by a multidisciplinary collaboration. This program is intended for clinical and research professionals who are involved in the care of patients with, and the study of, right heart disease, congenital heart disease, pulmonary hypertension, and associated disorders.
• Nurse practitioners
• Physician assistants
• Allied healthcare professionals
In the following fields:
– Critical care medicine
– Emergency medicine
– Internal medicine
– Vascular medicine
Supported by educational grants from: Abbott Laboratories; Acceleron Pharma Inc.; Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson; and United Therapeutics.
This internet enduring material activity is part of a series of activities. Participation in this activity is free of charge.
Release Date: May 04, 2022 -- Expiration Date: May 03, 2023
Faculty: Multiple Faculty,
Moderator: Dr. Bradley M. Wertheim, MD, is a member of the Pulmonary Vascular Disease Program at Brigham and Women’s Hospital. He specializes in the care of patients with pulmonary arterial hypertension (PAH) and complex heart-lung interactions.
Submassive PE: What is it Really and What is the Best Approach to Treatment? – Gregory Piazza, MD, MS, Associate Professor of Medicine, Harvard Medical School; Staff Physician, Cardiovascular Division, Section Head, Vascular Medicine Division, Brigham and Women’s Hospital
Acute PE and Impact on RV – Yolanda Bryce, MD, Assistant Professor, Weill Cornell Medicine; Assistant Attending, Memorial Sloan Kettering Cancer Center
Massive and Catastrophic PE: Strategies for Circulatory Support Both Pharmacologically and Mechanically – David M. Dudzinski, MD, FAHA, FACC, FASE, Assistant Professor, Harvard Medical School; Director, Cardiac Intensive Care Unit, Massachusetts General Hospital
Effects of Exercise Training on the Right Heart – Mary Beth Brown, PT, PhD, Associate Professor, University of Washington School of Medicine; Associate Professor, Rehabilitation Medicine, University of Washington School of Medicine
Critical Care and the Failing Right Heart
Drips to Machines – Supporting the Failing RH – Evelyn Horn, MD, Professor, Weill Cornell; Director, Advanced Heart Failure and Pulmonary Vascular Disease, NYPH-Weill Cornelll
Physiologic Impact of Mechanical Ventilation on the Right Heart – Inderjit Singh, MD, FRCP, Assistant Professor of Medicine, Yale School of Medicine; Director of Pulmonary Vascular Disease Program, Yale New Haven Hospital
By the end of the session the participant will be able to:
ACCME Activity #202288303
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
Individuals with no conﬂicts of interest to disclose:
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.